{"protocolSection":{"identificationModule":{"nctId":"NCT00132509","orgStudyIdInfo":{"id":"2000.208"},"organization":{"fullName":"Hospices Civils de Lyon","class":"OTHER"},"briefTitle":"FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke","officialTitle":"Comparison of the Classical Rt-PA Procedure (0.9mg/kg Over 60 Minutes) With a Longer Procedure With Lower Dose (0.8mg/kg Over 90 Minutes) in Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2009-02","overallStatus":"TERMINATED","whyStopped":"End of promotion by the sponsor","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2001-09"},"primaryCompletionDateStruct":{"date":"2008-08","type":"ACTUAL"},"completionDateStruct":{"date":"2008-08","type":"ACTUAL"},"studyFirstSubmitDate":"2005-08-19","studyFirstSubmitQcDate":"2005-08-19","studyFirstPostDateStruct":{"date":"2005-08-22","type":"ESTIMATED"},"lastUpdateSubmitDate":"2011-07-21","lastUpdatePostDateStruct":{"date":"2011-07-22","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Pr Paul TROUILLAS","oldOrganization":"Service de Neurologie, Hôpital Neurologique, Hospices Civils de Lyon"},"leadSponsor":{"name":"Hospices Civils de Lyon","class":"OTHER"}},"descriptionModule":{"briefSummary":"Data from the literature have suggested that a longer time of thrombolysis might be more effective in ischemic stroke. We, the investigators at Hospices Civils de Lyon, have designed a randomized protocol to test this hypothesis. Moreover, the therapeutic window is 7 hours.\n\nRt-PA (alteplase) is injected intravenously in the 2 arms of the study for a duration of 60 minutes in the arm with a \"classical dose\" and 90 minutes in the arm with a \"low dose-longer infusion\".\n\nThis is a study of the outcome at 90 days."},"conditionsModule":{"conditions":["Stroke, Acute"],"keywords":["rt-PA","thrombolysis","Acute ischemic stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["PARTICIPANT"]}},"enrollmentInfo":{"count":500,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"DFIL","type":"EXPERIMENTAL","interventionNames":["Drug: DFIL"]},{"label":"NINDS","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: NINDS"]}],"interventions":[{"type":"DRUG","name":"DFIL","description":"Alteplase : 0.8mg/kg over 90 minutes","armGroupLabels":["DFIL"]},{"type":"DRUG","name":"NINDS","description":"Alteplase : 0.9mg/kg over 60 minutes","armGroupLabels":["NINDS"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Modified Rankin score","timeFrame":"day 90"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Symptoms of ischemic stroke\n* Presence of a deficit measurable with National Institutes of Health Stroke Scale (NIHSS)\n* Lack of any hemorrhagic lesion on the computed tomography (CT) scan at entry\n* Time of therapy less than 7 hours after onset of stroke\n* Permanent or aggravating symptoms\n* Ages 18-81\n\nExclusion Criteria:\n\n* Lack of cerebral infarction or of cranial trauma within 3 weeks before therapy\n* No surgery within 14 days before therapy\n* History of cerebral bleeding\n* Blood pressure: systolic \\>185 mmHg and/or diastolic \\>110 mmHg\n* Minor symptoms or symptoms rapidly improving\n* Gastro-intestinal or urinary hemorrhage within 21 days\n* Arterial puncture within 7 days before therapy\n* Epileptic seizure at the beginning of stroke\n* Patients under oral anticoagulants or having received heparin within 48 hours, and with elevated activated partial thromboplastin time (aPTT)\n* Patients with elevated International Normalized Ratio (INR) or thrombocyte count \\< 100 x 10\\^9\n* Blood glucose value \\< 2.7 mmol/l or \\> 22.2 mmol/l\n* Cardiac, pulmonary, hepatic or renal failure, not allowing a study over 3 months\n* History of gastric ulcer within 15 days; gestation and menstruation","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"81 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Paul TROUILLAS, MD","affiliation":"Hospices Civils de Lyon","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Hôpital Pierre Wertheimer","city":"Bron","zip":"69677","country":"France","geoPoint":{"lat":45.73333,"lon":4.91667}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M13539","name":"Tissue Plasminogen Activator","relevance":"LOW"}],"browseBranches":[{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}